ID: h-c5dd93610a
Hypothesis
Locus coeruleus degeneration gates whether cholinergic dysfunction or amyloid/tau appears first
Early noradrenergic loss may shift inflammatory tone, amyloid clearance, and cholinergic resilience, thereby modulating the observed sequence of biomarkers.
EvidencePending (0%)📖 7 cit🗣 1 debates✓ 7 support✗ 2 oppose
✓ All Quality Gates Passed
🧪 Overview
Early noradrenergic loss may shift inflammatory tone, amyloid clearance, and cholinergic resilience, thereby modulating the observed sequence of biomarkers. The debate supports this mainly as a stratification axis and covariate rather than a primary causal program.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["APP Full Length<br/>Membrane Protein"]
B["BACE1 Beta-Secretase<br/>Cleavage at beta-site"]
C["sAPPbeta + CTFbeta<br/>C-terminal Fragment"]
D["Gamma-Secretase Complex<br/>PSEN1/PSEN2"]
E["Abeta42 Peptide<br/>Amyloidogenic Fragment"]
F["Abeta Oligomers<br/>Toxic Aggregates"]
G["Amyloid Plaques<br/>Extracellular Deposits"]
H["ADAM10 Alpha-Secretase<br/>Non-amyloidogenic Path"]
A --> B
B --> C
C --> D
D --> E
E --> F
F --> G
A --> H
H -.->|"competes with BACE1"| B
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style E fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style H fill:#1b5e20,stroke:#81c784,color:#81c784⚖️ Evidence
⚖️ Evidence Matrix7 supports2 contradicts
Supports
LC and NBM abnormalities can both be detected early in AD, making LC integrity a plausible ordering modifier in longitudinal studies.
Supports
Noradrenergic signaling is biologically linked to neuroinflammation and amyloid clearance programs relevant to sequence effects.
Supports
In vivo effects of cardiomyocyte-specific β-1 blockade on afterload- and frequency-dependent cardiac performance.
Supports
Relationships of Cerebrospinal Fluid Alzheimer's Disease Biomarkers and COMT, DBH, and MAOB Single Nucleotide Polymorphisms.
Supports
Mutant β(1)-adrenergic receptor improves REM sleep and ameliorates tau accumulation in a mouse model of tauopathy.
Supports
Norepinephrine Drives Sleep Fragmentation Activation of Asparagine Endopeptidase, Locus Ceruleus Degeneration, and Hippocampal Amyloid-β(42) Accumulation.
Supports
Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist.
Contradicts
LC measures are noisy proxies and may lose predictive value after controlling for age, APOE, vascular burden, sleep, and baseline pathology.
Contradicts
LC degeneration may be a parallel vulnerability marker rather than the determinant of disease ordering.
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — DBH
No curated PDB or AlphaFold mapping for DBH yet. Search RCSB →
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for DBH, ADRB1, ADRB2 from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for DBH, ADRB1, ADRB2.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
💰 Estimated Development
Cost
$0
Timeline
—
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▼ 0.7%
Volatility
Low
0.0027
Events (7d)
3
Price History
▼10.3%💾 Resource Usage
LLM Tokens
19,162
$0.0575
Total Cost
$0.0575
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF locus coeruleus integrity is experimentally reduced via DSP-4 lesioning in 3xTg-AD mice at 3 months of age, THEN cholinergic marker deficits (ChAT activity and high-affinity choline uptake) will em | ChAT activity will decline by ≥40% and ACh release will decrease by ≥30% at 5 months post-lesion, while amyloid PET signal (${}^{11}$C-PiB) and CSF p-tau181 wil | — no observation — | pending | 0.65 |
| IF cognitively normal older adults (60-80 years) are stratified by baseline LC integrity using neuromelanin-sensitive MRI, THEN those in the low-LC integrity quartile will exhibit significantly steepe | The low-LC integrity group will show ≥1.5% annual decline in FDG-PET metabolism and ≥20% reduction in CSF ACh concentration relative to baseline by 36 months, w | — no observation — | pending | 0.55 |
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF locus coeruleus integrity is experimentally reduced via DSP-4 lesioning in 3xTg-AD mice at 3 months of age, THEN cholinergic marker deficits (ChAT activity and high-affinity choline uptake) will emerge 2-3 months before detectable amyloid plaque burden or CSF p-tau increases in the lesioned cohor
Predicted outcome: ChAT activity will decline by ≥40% and ACh release will decrease by ≥30% at 5 months post-lesion, while amyloid PET signal (${}^{11}$C-PiB) and CSF p-
Falsification: If amyloid plaque density or CSF p-tau181 increases to pathological thresholds (≥30% above baseline) at or before the emergence of cholinergic deficits, the hypothesis that LC degeneration gates the t
pendingconf 55%
IF cognitively normal older adults (60-80 years) are stratified by baseline LC integrity using neuromelanin-sensitive MRI, THEN those in the low-LC integrity quartile will exhibit significantly steeper rates of decline in posterior cingulate cortex glucose metabolism (FDG-PET) and CSF ACh levels ove
Predicted outcome: The low-LC integrity group will show ≥1.5% annual decline in FDG-PET metabolism and ≥20% reduction in CSF ACh concentration relative to baseline by 36
Falsification: If amyloid-positive subjects with high LC integrity demonstrate equivalent or greater rates of cholinergic and metabolic decline compared to low-LC integrity subjects regardless of amyloid/tau status,
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.